Reference · Women
What the evidence shows in women.
Almost all of this research was done in men. That's the honest starting point — so this page flags what actually has female data, and the risks that are specific to women.
The default assumption across peptides, SARMs, and steroids is that what was measured in men applies to women. It often doesn't — dose response, metabolism, and the hormonal backdrop are different, and the female safety picture can diverge sharply. Where a compound has actually been tested in women, that's worth knowing. Where it hasn't, that's worth knowing too.
For anything androgenic — anabolic steroids and some SARMs — the dominant female-specific risk is virilization: voice deepening, facial and body hair, clitoral enlargement, and menstrual disruption. It's dose- and duration-dependent, and some of it — the voice changes especially — can be permanent. This is the single most important thing the male-dominated literature tends to gloss over. See the anabolic-steroid reference and side effects & safety.
- PT-141 (Bremelanotide) The rare one studied and approved specifically for women — FDA-cleared in 2019 (as Vyleesi) for low sexual desire (HSDD) in premenopausal women, on the back of two trials in ~1,250 women.
- Oxandrolone (Anavar) The androgen with the most actual research in women — studied for years in girls with Turner syndrome. It has the mildest virilizing potency of the steroids, but the risk is dose-dependent and never zero, and voice changes in particular can be permanent.
- Semaglutide & the GLP-1s Their trials enrolled large numbers of women, and they’re widely used off-label for PCOS and its insulin resistance. Important: contraindicated in pregnancy — guidance is to stop well before trying to conceive, and rapid metabolic improvement can restore ovulation unexpectedly.
- Kisspeptin-10 Studied in women for reproductive signalling — ovulation, and conditions like hypothalamic amenorrhea — where the female data is the point, not an afterthought.
- Gonadorelin A GnRH agent with a long history in women for fertility and ovulation induction; one of the few here with a genuinely female-centered clinical record.
- Oxytocin Core female-physiology roles — labour, lactation, bonding — and correspondingly the most female clinical data of any neuropeptide here.
The honest caveat
"Studied in women" is not the same as "safe for you," and several compounds here are contraindicated in pregnancy or breastfeeding. This is educational reference only — not medical advice, and there are no doses or protocols on this site. For how the grades work, see how we grade; browse everything in the full ledger.